Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madisen Fae Dorand

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Obesity Pillars|November 22, 2023
Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?Maria Paszkowiak, Madisen Fae Dorand, Jesse Richards
Obesity Pillars|January 13, 2025
Significantly higher rates of KIDINS220 polymorphisms in patients with obesity and end-stage renal diseaseJesse Richards, Madisen Fae Dorand, Maria Paszkowiak, et al.
The Journal of Clinical Psychiatry|November 29, 2023
Significant Decrease in Alcohol Use Disorder Symptoms Secondary to Semaglutide Therapy for Weight Loss: A Case SeriesJesse R Richards, Madisen Fae Dorand, Kyleigh Royal, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Obesity Pillars|November 22, 2023
Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?Maria Paszkowiak, Madisen Fae Dorand, Jesse Richards
Obesity Pillars|January 13, 2025
Significantly higher rates of KIDINS220 polymorphisms in patients with obesity and end-stage renal diseaseJesse Richards, Madisen Fae Dorand, Maria Paszkowiak, et al.
The Journal of Clinical Psychiatry|November 29, 2023
Significant Decrease in Alcohol Use Disorder Symptoms Secondary to Semaglutide Therapy for Weight Loss: A Case SeriesJesse R Richards, Madisen Fae Dorand, Kyleigh Royal, et al.
Pageof 1